Hypoglycaemic activity of Bixa orellana extract in the dog

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 30, Issue 4, 2008, Pages 301-305

  Russell, K R M ^a   Omoruyi, Felix O ^a,b   Pascoe, K O ^a   Morrison, E Y St A ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Annatto; Diabetes mellitus; Glucose lowering; Medicinal plants; Normoglycemia

Indexed keywords

ANTIDIABETIC AGENT; BIXA ORELLANA EXTRACT; C PEPTIDE; GLUCOSE; INSULIN; PLANT EXTRACT; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIXA ORELLANA; BIXACEAE; CONTROLLED STUDY; DOG; EXPERIMENTAL DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; GLYCEMIC CONTROL; INSULIN BLOOD LEVEL; INSULIN SYNTHESIS; MALE; MEAN RESIDENCE TIME; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; STREPTOZOCIN DIABETES;

ANIMALS; BIXACEAE; BLOOD GLUCOSE; C-PEPTIDE; CAROTENOIDS; DIABETES MELLITUS, EXPERIMENTAL; DOGS; FEMALE; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MEDICINE, TRADITIONAL; PLANT EXTRACTS; POSTPRANDIAL PERIOD; STREPTOZOCIN; TIME FACTORS; WEST INDIES;

EID: 52649177657     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2008.30.4.1186073     Document Type: Article

References (13)

1. Morrison, E.Y.St.A., West, M. A preliminary study of the effect of some West Indian medicinal plants on blood sugar levels in the dog. West Indian Med J 1982, 31: 194-7.
2. Morrison, E.Y.St.A., West, M.E. The effect of Bixa orellana (annatto) on blood sugar levels in the anaesthetised dog. West Indian Med J 1985, 34: 38-42.
3. Russell, K.R.M., Morrison, E.Y.St.A., Ragoobirsingh, D. The effect of annatto on insulin binding properties in the dog. Phytother Res 2005, 19: 433-6.
4. Beach, E.F., Turner, J.J. An enzymatic methodfor glucose determination in body fluids. Clin Chem 1958, 4: 462-5.
5. Bloomgarde, Z.T. New therapeutic approaches to non-insulin dependent diabetes mellitus. Endocr Pract 1997, 3(5): 307-12.
6. Johansen, K. Acarbose treatment of sulphonylurea-treated non-insulin dependent diabetics: A double-blind, cross-over comparison of an alpha glucosidase inhibitor with melformin. Diabetes Metab 1984, 10: 219-23.
7. Rendell, M. The role sulphonylureas in the management of type 2 diabetes mellitus. Drugs 2004, 63(12): 1339-58.
8. Clissold, S.P., Edwards, C. Acarbose: A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1988, 35: 214-43.
9. Joubert, P.H., Venter, H.L., Foukaridis, G.N. The effect of miglitol and acarbose after an oral glucose load: A novel hypoglycaemic mechanism? Br J Clin Pharmacol 1990, 30(3): 391-396.
10. Quezada-Calvillo, R., Robayo-Torres, C.C., Opekun, A.R., et al. Contribution of mucosal maltase-glucoamylase activities to mouse small intestinal starch alpha-glucogenesis. J Nutr 2007, 137(7): 1725-33.
11. Forst, T., Kunt, T., Pfutzner, A., Beyer, J., Wahren, J. New aspects on biological activity of C-pepide in IDDM patients. Exp Clin Endocrinol Diabetes 1998, 106(4): 270-6.
12. Hansen, B.F., Danielsen, G.M., Drejer, K., Sorensen, A.R., Wiberg, F.C., Klein, H.H., Lundemose, A.G. Sustained signaling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency. Biochem J 1996, 315: 271-9.
13. Grodsky, G.M., Landahl, H., Curry, A., Bennett, A. In Vitro Studies Suggesting a Two Compartmental Mode for Insulin Secretion. In: Structure and Metabolism of the Pancreatic Islets. Faulkner, S., Hellman, B., Taljedal, L.B. (Eds.). Pergamon: Oxford 1970, 409-20.